Both STAT3 and AKT2 have been reported in the literature to be closely related to liver fibrosis, and inhibiting STAT3 or AKT2 can treat liver fibrosis (Su et al., 2015; Reyes-Gordillo et al., 2019). This evidence concerns the gene AKT2 and Hepatic fibrosis.